These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30219213)

  • 1. Vulnerability in Heart Failure.
    Hauptman PJ
    J Card Fail; 2018 Aug; 24(8):485-486. PubMed ID: 30219213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hybrid approach to treatment of terminal heart failure].
    Davtian KV; Simonian GIu; Miasnikov RP; Bazaeva EV; Shanoian AS; Kharlap MS; Maksimova OB; Beregovskaia SA; Andreenko EIu; Firstova MI; Churilina VS; Boĭtsov SA
    Kardiologiia; 2014; 54(11):82-6. PubMed ID: 25902664
    [No Abstract]   [Full Text] [Related]  

  • 3. The Vulnerable Phase of Heart Failure.
    Gracia E; Singh P; Collins S; Chioncel O; Pang P; Butler J
    Am J Ther; 2018; 25(4):e456-e464. PubMed ID: 29985824
    [No Abstract]   [Full Text] [Related]  

  • 4. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).
    Lam CS; Solomon SD
    Eur J Heart Fail; 2014 Oct; 16(10):1049-55. PubMed ID: 25210008
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of long-term outcomes between narrow and broad QRS complex patients treated with cardiac resynchronization therapy.
    Yap LB; Nguyen ST; Qadir F; Ma SK; Muhammad Z; Koh KW; Ali Z; Tay GS; Daud A; Said A; Sahat N; Rebo R; Tamin SS; Hussin A; Kaur S; Omar R
    Acta Cardiol; 2016 Jun; 71(3):323-30. PubMed ID: 27594128
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac resynchronization therapy for mild heart failure: the time has come.
    Reynolds CR; Gold MR
    Circulation; 2011 Jan; 123(2):195-202. PubMed ID: 21242505
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonsurgical therapy for heart failure.
    Park KW
    Int Anesthesiol Clin; 2012; 50(3):1-21. PubMed ID: 22735717
    [No Abstract]   [Full Text] [Related]  

  • 9. Noninvasive monitoring of stroke volume with resynchronization devices in patients with ischemic cardiomyopathy.
    Kühne M; Bocchiardo M; Nägele H; Schaer B; Lippert M; Sticherling C; Osswald S
    J Card Fail; 2013 Aug; 19(8):577-82. PubMed ID: 23910588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights into ventricular interactions during cardiac resynchronization.
    Daubert C; Behaghel A; Martins RP
    J Am Coll Cardiol; 2013 Dec; 62(25):2404-2405. PubMed ID: 24013053
    [No Abstract]   [Full Text] [Related]  

  • 12. DDD pacemaker for severe heart failure-alternate to CRT.
    Krishnamani NC
    Indian Heart J; 2017; 69(3):345-348. PubMed ID: 28648429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 14. Regarding article "relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy".
    Fornwalt BK; León AR; Oshinski JN
    Circulation; 2011 Jul; 124(2):e37; author reply e38. PubMed ID: 21747062
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy reduces left ventricular energy loss.
    Kakizaki R; Nabeta T; Ishii S; Koitabashi T; Itatani K; Inomata T; Ako J
    Int J Cardiol; 2016 Oct; 221():546-8. PubMed ID: 27414737
    [No Abstract]   [Full Text] [Related]  

  • 17. Imaging electrical dyssynchrony.
    Faddis MN
    J Am Coll Cardiol; 2013 Jun; 61(24):2444-2445. PubMed ID: 23602773
    [No Abstract]   [Full Text] [Related]  

  • 18. Superresponse to cardiac resynchronization therapy.
    Steffel J; Ruschitzka F
    Circulation; 2014 Jul; 130(1):87-90. PubMed ID: 24982120
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac resynchronization therapy response in heart failure patients with different subtypes of true left bundle branch block.
    García-Seara J; Iglesias Alvarez D; Alvarez Alvarez B; Gude Sampedro F; Martínez Sande JL; Rodríguez-Mañero M; Kreidieh B; Fernández-López XA; González Melchor L; González Juanatey JR
    J Interv Card Electrophysiol; 2018 Jun; 52(1):91-101. PubMed ID: 29616388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out of Nowhere.
    Tatum R
    JACC Heart Fail; 2017 Aug; 5(8):615. PubMed ID: 28774398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.